Article Listing - TEIKOKU ACQUIRES RIGHTS TO ARTES

AESGP 1992 MEETING IN BARCELONA

20 April 1992

The European Proprietary Medicines Manufacturers' Association, the AESGP, is to hold its 28th annual meeting at the Hotel Princesa Sofia...

STRATEGIES TO ACHIEVE CRITICAL MASS

20 April 1992

A successful alliance within the pharmaceutical industry is one in which both partners make money over a long period of...

SINGAPORE DENIES US TRADE CHARGES

20 April 1992

Singapore's Ministry of Trade and Industry has described as "misleading and inaccurate" charges of unfair trade practices which have been...

TWO NEW LICENSING DEALS FOR ROBERTS

20 April 1992

Roberts Pharmaceutical Corp of the USA has entered into two licensing agreements concerning prescription products, one in Germany and...

ROCHE AND XENOVA CD4 DRUG DEAL

20 April 1992

Swiss major Hoffmann-La Roche Ltd and its US subsidiary Hoffmann-La Roche Inc have entered into a license agreement with the...

FISONS TO COPROMOTE EPIPEN

20 April 1992

US technology-based health care concern Survival Technology Inc has announced that Center Laboratories, the licensee for the anti-allergy EpiPen auto-injector...

HYDRO PHARMA TAKEOVER

20 April 1992

Norwegian pharmaceutical concern Hafslund Nycomed, through its subsidiary Nycomed Pharma, has finalized the takeover of Hydro Pharma (Marketletter February 24)...

L'OREAL 1991 RESULTS

20 April 1992

Fench cosmetics company L'Oreal, majority shareholder of the French pharmaceutical concern Synthelabo, posted net profits for 1991 of just over...

JANSSEN'S CISAPRIDE IN USA

20 April 1992

An advisory committee to the US Food and Drug Administra-tion has recommended approval of Janssen's cisapride, a gastro-esophageal reflux disease...

HAFSLUND NYCOMED'S CONTRAST AGENT

20 April 1992

Hafslund Nycomed is seeking approval in a number of countries to market a non-ionic X-ray contrast agent called Iodixanol. The...

Showing 94451-94460 of 95569 articles

Go to beginningPreviousNextGo to end